Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $10.19

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been assigned an average recommendation of “Hold” from the ten analysts that are currently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $10.1875.

A number of analysts have recently issued reports on AVAH shares. Barclays raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. Royal Bank Of Canada raised their target price on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a report on Friday, October 24th. Wall Street Zen upgraded shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Finally, JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price objective for the company from $6.00 to $10.00 in a research report on Thursday, September 18th.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $9.28 on Friday. The company has a market cap of $1.94 billion, a price-to-earnings ratio of 25.78 and a beta of 2.04. The business’s fifty day simple moving average is $9.05 and its two-hundred day simple moving average is $6.94. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million for the quarter. Research analysts anticipate that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of Aveanna Healthcare stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $11,267,181.00. Following the transaction, the insider owned 19,292,787 shares in the company, valued at $173,635,083. This trade represents a 6.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $13,500,000.00. Following the sale, the insider directly owned 362,746 shares of the company’s stock, valued at approximately $3,264,714. The trade was a 80.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,597,968 shares of company stock valued at $293,381,712 in the last quarter. 7.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several large investors have recently made changes to their positions in the business. Summit Partners L P purchased a new stake in shares of Aveanna Healthcare during the second quarter worth about $50,477,000. Vanguard Group Inc. grew its holdings in Aveanna Healthcare by 34.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after buying an additional 1,041,324 shares in the last quarter. AustralianSuper Pty Ltd bought a new stake in shares of Aveanna Healthcare during the third quarter valued at approximately $15,743,000. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Aveanna Healthcare by 70.1% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock worth $10,031,000 after buying an additional 466,022 shares in the last quarter. Finally, Algert Global LLC boosted its position in shares of Aveanna Healthcare by 120.1% during the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after acquiring an additional 557,898 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.